Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells

Cited by (692)

Items 301–400 of 692

1. MYC sensitises cells to apoptosis by driving energetic demand
   Joy Edwards-Hicks, Huizhong Su, Maurizio Mangolini, Kubra Karaosmanoglu Yoneten, Jimi C. Wills, Giovanny Rodriguez Blanco, Christine S. Young, Kevin Cho, Heather S. Barker, Morwenna Muir et al. · 2022 · Nature Communications
2. Emerging tale of UPR and cancer: an essentiality for malignancy
   Younis Hazari, Arif Bashir, Ehtisham Ul Haq, Khalid Majid Fazili · 2016 · Tumor Biology
3. Glucose-dependent anaplerosis in cancer cells is required for cellular redox balance in the absence of glutamine
   Naniye Malli Cetinbas, Jessica Sudderth, Robert C. Harris, Aysun Cebeci, Gian Luca Negri, Ömer H. Yilmaz, Ralph J. DeBerardinis, Poul H. B. Sorensen · 2016 · Scientific Reports
4. Altered metabolism in head and neck squamous cell carcinoma: an opportunity for identification of novel biomarkers and drug targets
   Vlad Constantin Sandulache, Jeffrey N. Myers · 2011 · Head & Neck
5. Metabolic Pathways, Enzymes, and Metabolites: Opportunities in Cancer Therapy
   Rishabh Kumar, Anurag Mishra, Priyanka Gautam, Zainab Feroz, Sivakumar Vijayaraghavalu, Eviania Likos, Girish C. Shukla, Munish Kumar · 2022 · Cancers
6. Metabolic reprogramming by tobacco-specific nitrosamines (TSNAs) in cancer
   Saharnaz Sarlak, Claude Lalou, Nívea Dias Amoêdo, Rodrigue Rossignol · 2019 · Seminars in Cell and Developmental Biology
7. ETA: Robust software for determination of cell specific rates from extracellular time courses
   Taylor A. Murphy, Jamey D. Young · 2013 · Biotechnology and Bioengineering
8. THZ1 suppresses human non-small-cell lung cancer cells in vitro through interference with cancer metabolism
   Zhu-Jun Cheng, Du-Ling Miao, Qiu-Yun Su, Xiao-Li Tang, Xiao-Lei Wang, Li-bin Deng, Huidong Shi, Hong‐Bo Xin · 2018 · Acta Pharmacologica Sinica
9. Action at a Distance: Allostery and the Development of Drugs to Target Cancer Cell Metabolism
   Byron DeLaBarre, Jonathan Hurov, Giovanni Cianchetta, Stuart Murray, Lenny Dang · 2014 · Chemistry & Biology
10. A clinically attainable dose of L‐asparaginase targets glutamine addiction in lymphoid cell lines
    Koichi Sugimoto, Hiroshi I. Suzuki, Tsutomu Fujimura, Asami Ono, Naoko Kaga, Yasushi Isobe, Makoto Sasaki, Hikari Taka, Kohei Miyazono, Norio Komatsu · 2015 · Cancer Science
11. Dying for Something to Eat: How Cells Respond to Starvation
    Alfredo Caro‐Maldonado, Cristina Muñoz‐Pinedo · 2011 · The Open Cell Signaling Journal
12. USP29 coordinates MYC and HIF1α stabilization to promote tumor metabolism and progression
    Rongfu Tu, Wenqian Kang, Mengjie Yang, Liyuan Wang, Qing Bao, Zhi Chen, Yang Dong, Jingchao Wang, Jue Jiang, Hudan Liu et al. · 2021 · Oncogene
13. Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling
    Lilia Alberghina, Daniela Gaglio, Cecilia Gelfi, Rosa Maria Moresco, Giancarlo Mauri, Paola Bertolazzi, Cristina Messa, Maria Carla Gilardi, Ferdinando Chiaradonna, Marco Vanoni · 2012 · Frontiers in Physiology
14. A prospective strategy leveraging nanomedicine for cancer therapy: Pouring ferroptosis on apoptosis
    Yutian Xia, Jianzhong Zhang, Gang Liu · 2022 · Nano Today
15. Metabolic Perturbation and Potential Markers in Patients with Esophageal Cancer
    Xianlan Zhu, Kun Wang, Gaoshuang Liu, Yuqing Wang, Jin Xu, Linsheng Liu, Mengjie Li, Jian Shi, Jiye Aa, YU Lianzhen · 2017 · Gastroenterology Research and Practice
16. Myc, Mondo, and Metabolism
    Elizabeth Sloan, Donald E. Ayer · 2010 · Genes & Cancer
17. Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment
    Zheng, Xiang, Mansouri, Siavash, Krager, Annika, Grimminger, Friedrich, Seeger, Werner, Pullamsetti, Soni S., Wheelock, Craig E., Savai, Rajkumar · 2020 · European Respiratory Review
18. Inhibition of the proline metabolism rate-limiting enzyme P5CS allows proliferation of glutamine-restricted cancer cells
    Samantha J Linder, Tiziano Bernasocchi, Bárbara Martínez-Pastor, Kelly D. Sullivan, Matthew D. Galbraith, Caroline A. Lewis, Christina M. Ferrer, Ruben Boon, Giórgia Gobbi da Silveira, Hyo Min Cho et al. · 2023 · Nature Metabolism
19. Metformin Impairs Glutamine Metabolism and Autophagy in Tumour Cells
    Serena Saladini, Michele Aventaggiato, Federica Barreca, Emanuela Morgante, Luigi Sansone, Matteo Antonio Russo, Marco Tafani · 2019 · Cells
20. Targeting MYC Dependence by Metabolic Inhibitors in Cancer
    Himalee S. Sabnis, Ranganatha R. Somasagara, Kevin D. Bunting · 2017 · Genes
21. MYC, Metabolic Synthetic Lethality, and Cancer
    Annie Lee Hsieh, Chi Van Dang · 2016 · Recent results in cancer research/Recent Results in Cancer Research
22. Temporal Molecular and Biological Assessment of an Erlotinib-Resistant Lung Adenocarcinoma Model Reveals Markers of Tumor Progression and Treatment Response
    Zoë Weaver Ohler, Simone Difilippantonio, Julián Carretero, Philip Martin, Rajaâ El Meskini, Anthony J. Iacovelli, Michelle Gumprecht, Alan Kulaga, Theresa M. Guerin, Jerome Schlomer et al. · 2012 · Cancer Research
23. Oncosecretomics coupled to bioenergetics identifies α-amino adipic acid, isoleucine and GABA as potential biomarkers of cancer: Differential expression of c-Myc, Oct1 and KLF4 coordinates metabolic changes
    Nadège Bellancé, Lisa Pabst, Genevara Allen, Rodrigue Rossignol, Deepak Nagrath · 2012 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
24. Glutaminolysis and carcinogenesis of oral squamous cell carcinoma
    Marcel Cetindis, Thorsten Biegner, Adelheid Munz, Peter Teriete, Siegmar Reinert, Martin R. Grimm · 2015 · European Archives of Oto-Rhino-Laryngology
25. Alteration of cellular metabolism in cancer cells and its therapeutic prospects
    Biranchi Narayan Biswal, SuryaNarayan Das, BijoyKumar Das, Rachna Rath · 2017 · Journal of Oral and Maxillofacial Pathology
26. Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor
    Carolyn M. Jablonowski, Waise Quarni, Shivendra Vikram Singh, Haiyan Tan, Dhanushka Hewa Bostanthirige, Hongjian Jin, Jie Fang, Ti‐Cheng Chang, David Finkelstein, Ji‐Hoon Cho et al. · 2023 · eLife
27. Facile Synthesis [5-13C-4-2H2]-L-Glutamine for Hyperpolarized MRS Imaging of Cancer Cell Metabolism
    Wenchao Qü, Zhihao Zha, Brian P. Lieberman, Anthony Mancuso, Mathew Stetz, Rahim Rizzi, Karl Plöessl, David R. Wise, Craig B. Thompson, Hank F. Kung · 2011 · Academic Radiology
28. The activities of MYC, MNT and the MAX-interactome in lymphocyte proliferation and oncogenesis
    Jason M. Link, Peter J. Hurlin · 2014 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
29. Long noncoding RNA OIP5‐AS1 acts as a competing endogenous RNA to promote glutamine catabolism and malignant melanoma growth by sponging miR‐217
    Wenkang Luan, Xuanfeng Zhang, Hongru Ruan, Jinlong Wang, Xuefeng Bu · 2019 · Journal of Cellular Physiology
30. miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase
    Wenkang Luan, Zhou Zhou, Yan Zhu, Yun Fei Xia, Jinlong Wang, Bin Xu · 2017 · Biochemical and Biophysical Research Communications
31. Metabolic alterations in bladder cancer: applications for cancer imaging
    Terry C. Whyard, Wayne C. Waltzer, Douglas Waltzer, Victor Romanov · 2016 · Experimental Cell Research
32. MicroRNA-153 regulates glutamine metabolism in glioblastoma through targeting glutaminase
    Zhenyang Liu, Junyu Wang, Yunjun Li, Juan Fan, Lihua Chen, Ruxiang Xu · 2017 · Tumor Biology
33. The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy
    Gang Wang, Junjie Wang, Hua Zhao, Jing Wang, Shing Shun Tony To · 2015 · Archives of Biochemistry and Biophysics
34. Glutaminase inhibition in multiple myeloma induces apoptosisviaMYC degradation
    Madlen Effenberger, Kathryn S. Bommert, Viktoria Kunz, Jessica Kruk, Ellen Leich, Martina Rudelius, Ralf Christian Bargou, Kurt Bommert · 2017 · Oncotarget
35. L’effet Warburg
    Julie Razungles, Vincent Cavaillès, Stéphan Jalaguier, Catherine Teyssier · 2013 · médecine/sciences
36. Glutaminase expression is a poor prognostic factor in node-positive triple-negative breast cancer patients with a high level of tumor-infiltrating lymphocytes
    Joo Young Kim, Sun‐Hee Heo, Seul Ki Choi, In Hye Song, In Ah Park, Young‐Ae Kim, Hye Seon Park, Suk Young Park, Won Seon Bang, Gyungyub Gong et al. · 2017 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
37. Non-coding RNAs rewire cancer metabolism networks
    Xiaorong Lin, Zhi‐Yong Wu, Hai Hu, Man‐Li Luo, Erwei Song · 2021 · Seminars in Cancer Biology
38. Biological role of metabolic reprogramming of cancer cells during epithelial‑mesenchymal transition (Review)
    Mingzhe Li, Xin Bu, Bolei Cai, Ping Liang, Kai Li, Xuan Qu, Liangliang Shen · 2018 · Oncology Reports
39. GABA selectively increases mucin-1 expression in isolated pig jejunum
    Hannah‐Sophie Braun, Gerhard Sponder, Robert Pieper, Jörg Rudolf Aschenbach, Carolin Deiner · 2015 · Genes & Nutrition
40. Diabetes and Its Link with Cancer: Providing the Fuel and Spark to Launch an Aggressive Growth Regime
    Sanket Joshi, Menghan Liu, Nigel A. Turner · 2015 · BioMed Research International
41. Protein arginine methyltransferase 3: A crucial regulator in metabolic reprogramming and gene expression in cancers
    Shih‐Han Hsu, Wen‐Chun Hung · 2022 · Cancer Letters
42. Metabolic Reprogramming in Metastatic Melanoma with Acquired Resistance to Targeted Therapies: Integrative Metabolomic and Proteomic Analysis
    Laura Soumoy, Corentin Schepkens, Mohammad Krayem, Ahmad Najem, Vanessa Tagliatti, Ghanem Ghanem, Sven Saussez, Jean‐Marie Colet, Fabrice Journé · 2020 · Cancers
43. Glutaminase inhibition as potential cancer therapeutics: current status and future applications
    Rajath Cyriac, Kwang‐Ho Lee · 2023 · Journal of Enzyme Inhibition and Medicinal Chemistry
44. Molecular Pathways: Regulation of Metabolism by RB
    Brian F. Clem, Jason Alan Chesney · 2012 · Clinical Cancer Research
45. Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence
    Roopak Murali, Vaishnavi Balasubramaniam, Satish Srinivas, Sandhya Sundaram, Ganesh Venkatraman, Sudha R. Warrier, Arun Dharmarajan, Rajesh Kumar Gandhirajan · 2023 · Metabolites
46. Metabotypes of breast cancer cell lines revealed by non-targeted metabolomics
    Sébastien Dubuis, Franziska Baenke, Nina Scherbichler, Leila T. Alexander, Almut Schulze, Nicola Zamboni · 2016 · Metabolic Engineering
47. O-GlcNAcylation of YY1 stimulates tumorigenesis in colorectal cancer cells by targeting SLC22A15 and AANAT
    Guo‐Qing Zhu, Mingping Qian, Liesheng Lu, Yan Chen, Xiao Zhang, Qi Wu, Ya Liu, Zhixuan Bian, Yueyue Yang, Susu Guo et al. · 2019 · Carcinogenesis
48. Metabolic regulation of Drosophila apoptosis through inhibitory phosphorylation of Dronc
    Chih‐Sheng Yang, Michael J. Thomenius, Eugene C. Gan, Wanli Tang, Christopher D. Freel, Thomas J. S. Merritt, Leta K. Nutt, Sally A. Kornbluth · 2010 · The EMBO Journal
49. Glutamine-β-cyclodextrin for targeted doxorubicin delivery to triple-negative breast cancer tumors via the transporter ASCT2
    Ping Zhou, Xingmei Liang, Ce Zhou, Jiaqi Qin, Chunyu Hou, Zhiyan Zhu, Wenxue Zhang, Shuqing Wang, Diansheng Zhong · 2019 · Journal of Materials Chemistry B
50. Warburg and Krebs and related effects in cancer
    Judith E. Unterlass, Nicola J. Curtin · 2019 · Expert Reviews in Molecular Medicine
51. Glutamine metabolism regulates FLIP expression and sensitivity to TRAIL in triple-negative breast cancer cells
    Marta Mauro-Lizcano, Abelardo López‐Rivas · 2018 · Cell Death and Disease
52. Effects of Ferroptosis on the Metabolome in Cardiac Cells: The Role of Glutaminolysis
    Keishla M. Rodríguez‐Graciani, Xavier R. Chapa‐Dubocq, Esteban J. Ayala-Arroyo, Ivana Chaves‐Negrón, Sehwan Jang, Nataliya Chorna, Taber S. Maskrey, Peter Wipf, Sabzali A. Javadov · 2022 · Antioxidants
53. HDAC6 inhibitors sensitize non-mesenchymal triple-negative breast cancer cells to cysteine deprivation
    Tahiyat Alothaim, Morgan Charbonneau, Xiaohu Tang · 2021 · Scientific Reports
54. Glutamine metabolism, a double agent combating or fuelling hepatocellular carcinoma
    Razan Abou Ziki, Sabine Colnot · 2024 · JHEP Reports
55. Repression of SRF target genes is critical for Myc‐dependent apoptosis of epithelial cells
    Katrin E. Wiese, Heidi M. Haikala, Björn von Eyß, Elmar Wolf, Cyril Esnault, Andreas Rosenwald, Richard Treisman, Juha T. Klefström, Martin Eilers · 2015 · The EMBO Journal
56. Metabolic regulation in HPV associated head and neck squamous cell carcinoma
    Vaishali Chandel, Sibi Raj, Prabhat Kumar, Shilpi Gupta, Anupam Dhasmana, Kavindra Kumar Kesari, Janne Ruokolainen, Pravesh Mehra, Bhudev Chandra Das, Mohammad Amjad Kamal et al. · 2020 · Life Sciences
57. Targeting glutaminase 1 (GLS1) by small molecules for anticancer therapeutics
    Yangyang Chen, Lun Tan, Jing Gao, Congcong Lin, Fengbo Wu, Yang Li, Jifa Zhang · 2023 · European Journal of Medicinal Chemistry
58. Arginine deiminase originating fromLactococcus lactisssp.lactisAmerican Type Culture Collection (ATCC) 7962 induces G1-phase cell-cycle arrest and apoptosis in SNU-1 stomach adenocarcinoma cells
    Jong‐Eun Kim, Seoyoung C. Kim, Ki Won Lee, Hyong Joo Lee · 2009 · British Journal Of Nutrition
59. Glutamine Starvation Affects Cell Cycle, Oxidative Homeostasis and Metabolism in Colorectal Cancer Cells
    Martina Spada, Cristina Piras, Giulia Diana, Vera Piera Leoni, Daniela Virginia Frau, Gabriele Serreli, Gabriella Simbula, Roberto Loi, Antonio Noto, Federica Murgia et al. · 2023 · Antioxidants
60. Targeting fatty acid uptake and metabolism in cancer cells: A promising strategy for cancer treatment
    Rahul Mallick, Prasenjit Bhowmik, Asim K. Duttaroy · 2023 · Biomedicine & Pharmacotherapy
61. Coordination of glucose and glutamine utilization by an expanded Myc network
    Mohan Rao Kaadige, Marc Elgort, Donald E. Ayer · 2010 · Transcription
62. MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation
    Alberto Delaidelli, Gian Luca Negri, Asad Jan et al. · 2017 · Cell Death and Differentiation
63. Development and Characterization of a Fluorescent Probe for GLS1 and the Application for High-Throughput Screening of Allosteric Inhibitors
    Xi Jin Xu, Zijian Kuang, Jie Han, Ying Meng, Lei Li, Hongyu Luan, Pengfei Xu, Jubo Wang, Cheng Luo, Hong Ding et al. · 2019 · Journal of Medicinal Chemistry
64. The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor
    Kathryn M. Lemberg, Liang Zhao, Ying Wu, Vijayabhaskar Veeravalli, Jesse Alt, Joanna Marie H. Aguilar, Ranjeet Prasad Dash, Jenny Lam, Lukáš Tenora, Chabely Rodriguez et al. · 2019 · Molecular Cancer Therapeutics
65. Myc-induced glutaminolysis bypasses HIF-driven glycolysis in hypoxic small cell lung carcinoma cells
    Thorén, Matilda Munksgaard, Vaapil, Marica, Staaf, Johan, Planck, Maria, Johansson, Martin E., Mohlin, Sofie, Påhlman, Sven · 2017 · Oncotarget
66. Glutamine, Glucose and other Fuels for Cancer
    María Victoria Ruiz-Pérez, Francisca Sánchez‐Jiménez, Francisco José Alonso, Juan Segura, Javier Márquez, Miguel Ángel Medina · 2014 · Current Pharmaceutical Design
67. Histidine is selectively required for the growth of Myc‐dependent dedifferentiation tumours in the Drosophila CNS
    Francesca Froldi, Panayotis Pachnis, Milán Szuperák, Olivia Costas, Tharindu Fernando, Alex P. Gould, Louise Y Cheng · 2019 · The EMBO Journal
68. p53 and regulation of tumor metabolism
    Xiaolu Yang, Peng Jiang, Wenjing Du · 2013 · Journal of Carcinogenesis
69. microRNAs Tune Oxidative Stress in Cancer Therapeutic Tolerance and Resistance
    Wen Cai Zhang · 2019 · International Journal of Molecular Sciences
70. Survival of the fittest: metabolic adaptations in cancer
    Marcelo J. Berardi, Valeria R. Fantin · 2010 · Current Opinion in Genetics & Development
71. Neuroblastoma: Emerging trends in pathogenesis, diagnosis, and therapeutic targets
    Santharam S. Katta, Veerababu Nagati, Atreya S.V. Paturi, Swati P. Murakonda, Ajay B. Murakonda, Manoj K. Pandey, Subash C. Gupta, Anil Kumar Pasupulati, Kishore B. Challagundla · 2023 · Journal of Controlled Release
72. Dynamic metabolic reprogramming in dendritic cells: An early response to influenza infection that is essential for effector function
    Svetlana Rezinciuc, Lavanya Bezavada, Azadeh Bahadoran, Susu Duan, Ruoning Wang, Daniel López‐Ferrer, Erika E. Zink, David Finklestein, Douglas R. Green, Ljiljana Paša‐Tolić et al. · 2020 · PLoS Pathogens
73. Nutritional Stress in Head and Neck Cancer Originating Cell Lines: The Sensitivity of the NRF2-NQO1 Axis
    Lidija Milković, Marko Tomljanović, Ana Čipak Gašparović, Renata Novak Kujundžić, Dina Šimunić, Paško Konjevoda, Anamarija Mojzeš, Nikola Đaković, Neven Žarković, Koraljka Gall‐Tros̆elj · 2019 · Cells
74. Components of cancer metabolism and therapeutic interventions
    John Singleterry, Annapoorna Sreedhar, Yunfeng Zhao · 2014 · Mitochondrion
75. Alanyl-glutamine but not glycyl-glutamine improved the proliferation of enterocytes as glutamine substitution in vitro
    Bie Tan, Honglan Liu, Guangzu He · 2017 · Amino Acids
76. Simultaneous activation and inhibition of autophagy sensitizes cancer cells to chemotherapy
    Kwan-Hwa Chi, Yu‐Shan Wang, Yi-Chun Huang, Hsin-Chien Chiang, Mau‐Shin Chi, Chau‐Hwa Chi, Hsin-Ell Wang, Shang-Jyh Kao · 2016 · Oncotarget
77. pH-sensitive tumor-tropism hybrid membrane-coated nanoparticles for reprogramming the tumor microenvironment and boosting the antitumor immunity
    Jie Zhang, Liwen Wei, Xiaocao Ma, Jingguo Wang, Siping Liang, Kang Chen, Minhao Wu, Li Niu, Yuanqing Zhang · 2023 · Acta Biomaterialia
78. SLC1A3 facilitates Newcastle disease virus replication by regulating glutamine catabolism
    Pan-Rao Liu, N. Tang, C. Meng, Yun-Cong Yin, X. Qiu, L. Tan, Ying-Jie Sun, Cui-Ping Song, Weiwei Liu, Ying Liao et al. · 2022 · Virulence
79. Metabolic Constants and Plasticity of Cancer Cells in a Limiting Glucose and Glutamine Microenvironment—A Pyruvate Perspective
    Angela M. Otto · 2020 · Frontiers in Oncology
80. Cysteine is a limiting factor for glioma proliferation and survival
    Victor Ruiz‐Rodado, Tyrone Dowdy, Adrian Lita, Tamalee R. Kramp, Meili Zhang, Jinkyu Jung, Ana Dios‐Esponera, Lumin Zhang, Christel C. Herold‐Mende, Kevin A. Camphausen et al. · 2021 · Molecular Oncology
81. 1,25-Dihydroxyvitamin D inhibits glutamine metabolism in Harvey-ras transformed MCF10A human breast epithelial cell
    Xuanzhu Zhou, Wei Zheng, G. A. Nagana Gowda, Daniel Raftery, Shawn S. Donkin, Brian J. Bequette, Dorothy Teegarden · 2016 · The Journal of Steroid Biochemistry and Molecular Biology
82. High-glycolytic cancers and their interplay with the body’s glucose demand and supply cycle
    Edward Henry Mathews, Leon Liebenberg, Ruaan Pelzer · 2010 · Medical Hypotheses
83. 2-Deoxyglucose treatment complements the cisplatin- or BH3-only mimetic-induced suppression of neuroblastoma cell growth
    Jiin‐Haur Chuang, Ming-Huei Chou, Ming‐Hong Tai, Tsu‐Kung Lin, Chia‐Wei Liou, Ting‐Ya Chen, Wen‐Ming Hsu, Pei‐Wen Wang · 2013 · The International Journal of Biochemistry & Cell Biology
84. Metabolic and Amino Acid Alterations of the Tumor Microenvironment
    Petr Štěpka, Vít Všianský, Martina Raudenská, Jaromír Gumulec, Vojtěch Adam, Michal Masařík · 2020 · Current Medicinal Chemistry
85. SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism Via C-Myc/GLS1 Axis
    Kangdi Xu, Jun Ding, Lingfeng Zhou, Dazhi Li, Jia Luo, Wenchao Wang, Mingge Shang, Bingyi Lin, Lin Zhou, Shusen Zheng · 2022 · Cells
86. Transcriptomic-metabolomic reprogramming in EGFR-mutant NSCLC early adaptive drug escape linking TGFβ2-bioenergetics-mitochondrial priming
    Praveena Shree Thiagarajan, Xiaoliang Wu, Wei Zhang, Ivy Shi, Rakesh K. Bagai, Patrick S. Leahy, Yan Feng, Martina L. Veigl, Daniel J. Lindner, David Danielpour et al. · 2016 · Oncotarget
87. Dealing with hunger: Metabolic stress responses in tumors
    Mei Kong, Michael A. Reid · 2013 · Journal of Carcinogenesis
88. Studying Myc’s Role in Metabolism Regulation
    Anne Le, Chi Van Dang · 2013 · Methods in molecular biology
89. Insights into the pathophysiology of catch-up compared with non-catch-up growth in children born small for gestational age: an integrated analysis of metabolic and transcriptomic data
    Adam Stevens, C Bonshek, Andrew James Whatmore, Imogen Butcher, Daniel Hanson, Chiara De Leonibus, Mohamad Guftar Shaikh, Marie Brown, Elaine O’Shea, Suresh Victor et al. · 2014 · The Pharmacogenomics Journal
90. Glutamate dehydrogenase requirement for apoptosis induced by aristolochic acid in renal tubular epithelial cells
    Victor Romanov, Terry C. Whyard, Radha Bonala, Francis Johnson, Arthur P. Grollman · 2011 · APOPTOSIS
91. Blocking the utilization of glucose induces the switch from senescence to apoptosis in pseudolaric acid B-treated human lung cancer cells in vitro
    Guo‐Dong Yao, Jingyu Yang, Xiuxiu Li, Xiaoyu Song, Toshihiko Hayashi, Shin‐ichi Tashiro, Satoshi Onodera, Shao‐Jiang Song, Takashi Ikejima · 2017 · Acta Pharmacologica Sinica
92. Glucose and glutamine metabolism control by APC and SCF during the G1-to-S phase transition of the cell cycle
    Irving Omar Estévez-García, Verónica Cordoba-Gonzalez, Eleazar Lara‐Padilla, Abel Fuentes-Toledo, Ramcés Falfán‐Valencia, Rafael Campos‐Rodríguez, Edgar Abarca‐Rojano · 2014 · Journal of Physiology and Biochemistry
93. Aglycemia keeps mitochondrial oxidative phosphorylation under hypoxic conditions in HepG2 cells
    Lydie Plecitá‐Hlavatá, Jan Ježek, Petr Ježek · 2015 · Journal of Bioenergetics and Biomembranes
94. The Molecular ‘Myc-anisms’ behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics
    Jessica McAnulty, Analisa V. DiFeo · 2020 · International Journal of Molecular Sciences
95. Alone and Together: Current Approaches to Targeting Glutaminase Enzymes As Part of Anti-Cancer Therapies
    Thuy‐Tien T. Nguyen, William P. Katt, Richard A. Cerione · 2022 · Future Drug Discovery
96. Integrative Network-based Analysis of Magnetic Resonance Spectroscopy and Genome Wide Expression in Glioblastoma multiforme
    Dieter Henrik Heiland, Irina Mader, Pascal Schlosser, Dietmar Pfeifer, Maria Stella Carro, Thomas Lange, Ralf Schwarzwald, Ioannis Vasilikos, Horst Urbach, Astrid Weyerbrock · 2016 · Scientific Reports
97. Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs
    Annamaria Cimini, Michele d’Angelo, Elisabetta Benedetti, Barbara D’Angelo, Giulio Laurenti, Andrea Antonosante, Loredana Cristiano, Antonella Di Mambro, Marcella Barbarino, Vanessa Castelli et al. · 2016 · Journal of Cellular Physiology
98. From Prokaryotes to Cancer: Glutamine Flux in Multicellular Units
    Ayelet Erez, Ilana Kolodkin‐Gal · 2017 · Trends in Endocrinology and Metabolism
99. Mechanistic Study of the Deamidation Reaction of Glutamine: A Computational Approach
    Mohammad A. Halim, Mansour H. Almatarneh, Raymond A. Poirier · 2014 · The Journal of Physical Chemistry B
100. Asparagine, a critical limiting metabolite during glutamine starvation
     Jie Jiang, Natalya N. Pavlova, Ji Zhang · 2018 · Molecular & Cellular Oncology